基于建模的方法支持仿制药监管提交-实用考虑和案例研究
Prajwala Karnati1, Aditya Murthy1, Manoj Gundeti1
1Biopharmaceutics Department, Global Clinical Management, Dr. Reddy's Laboratories Ltd., Hyderabad, India.
The AAPS journal
|June 23, 2023
概括
基于模型的药物开发 (MiDD) 使用生理学基础的药理动力学 (PBPK) 建模来预测药物暴露. 本概述侧重于PBPK用于仿制药开发和生物豁免应用,提供实用指导.
科学领域:
- 药理动力学和药物新陈代谢
- 监管科学 监管科学
- 制药发展 制药发展
背景情况:
- 模型信息化药物开发 (MiDD) 使用定量工具预测体内药物暴露.
- 基于生理学上的药理动力学 (PBPK) 建模是MiDD的一个关键工具,旨在降低开发成本并加速患者获得药物的机会.
研究的目的:
- 为专门用于仿制药开发的PBPK建模方法提供概述.
- 在生物豁免申请中强调PBPK建模的应用.
- 解决常见的陷,并为监管提交中的基于模型的理由提供实际指导.
主要方法:
- 对与仿制药开发相关的PBPK建模方法的审查.
- 专注于生物豁免申请和监管提交战略.
- 包括内部案例研究来说明实际实施.
主要成果:
- 识别应用PBPK模型对监管缺陷的常见挑战和陷.
- 通过案例研究,通过PBPK模型证明生物豁免的明确途径.
- 减少PBPK理论知识和在仿制药开发中的实际应用之间的差距.
结论:
- 在仿制药开发中,PBPK建模是一个有价值的工具,特别是在支持生物豁免应用中.
- 实际的案例研究可以弥合PBPK理论与其监管应用之间的差距.
- 这项工作为利用PBPK建模克服仿制药开发中的监管障碍提供了路线图.
相关概念视频
Model Approaches for Pharmacokinetic Data: Physiological Models
78
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
78
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
99
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
99
Model Approaches for Pharmacokinetic Data: Compartment Models
139
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
139
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
97
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
97


